Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: A prospective study

The Lancet Respiratory Medicine

Volumn 3, Issue 8, 2015, Pages 613-620

  Guerra, Stefano ^a,c   Halonen, Marilyn ^a   Vasquez, Monica M ^a,b   Spangenberg, Amber ^a   Stern, Debra A ^a   Morgan, Wayne J ^a   Wright, Anne L ^a   Lavi, Iris ^c   Tarès, Lluïsa ^c   Carsin, Anne Elie ^c,d   Dobaño, Carlota ^e   Barreiro, Esther ^f   Zock, Jan Paul ^c   Martínez Moratalla, Jesús ^g   Urrutia, Isabel ^h   Sunyer, Jordi ^c,d   Keidel, Dirk ⁱ   Imboden, Medea ⁱ   Probst Hensch, Nicole ⁱ   Hallberg, Jenny ^j   Melén, Erik ^j   Wickman, Magnus ^j   Bousquet, Jean ^k,l   Belgrave, Danielle C M ^m   Simpson, Angela ^m   Custovic, Adnan ^m   Antó, Josep M ^c,d   Martinez, Fernando D ^a   more..

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^h HOSPITAL DE GALDAKAO   (Spain)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

^j KAROLINSKA INSTITUTE   (Sweden)

^k MONTPELLIER UNIVERSITY HOSPITAL   (France)

^l CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^m MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLARA CELL 16 PROTEIN; CLARA CELL PROTEIN; UNCLASSIFIED DRUG; SCGB1A1 PROTEIN, HUMAN; UTEROGLOBIN;

ADULT; ADULTHOOD; AGE; AGED; ARTICLE; ASTHMA; BODY HEIGHT; CHILD; CHILDHOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LIFESPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESPIRATORY AIRFLOW; SEX DIFFERENCE; SMOKING; ADOLESCENT; ADVERSE EFFECTS; BLOOD; COMPLICATION; LUNG; LUNG DISEASES, OBSTRUCTIVE; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; RESPIRATORY FAILURE; RISK FACTOR; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SMOKING; TIME FACTORS; UTEROGLOBIN; YOUNG ADULT;

EID: 84939464587     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00196-4     Document Type: Article

References (44)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
2. Guerra S, Martinez FD Natural history. Asthma and COPD: basic mechanisms and clinical management 2008, 23-35. Academic Press, Waltham, MA. 2nd edn. P.J. Barnes, J.M. Drazen, S.I. Rennard, N.C. Thomson (Eds.).
3. Burrows B, Knudson RJ, Cline MG, Lebowitz MD Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977, 115:195-205.
4. Silverman EK, Sandhaus RA Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med 2009, 360:2749-2757.
5. Broeckaert F, Bernard A Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy 2000, 30:469-475.
6. Mukherjee AB, Zhang Z, Chilton BS Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily. Endocr Rev 2007, 28:707-725.
7. Lakind JS, Holgate ST, Ownby DR, et al. A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers 2007, 12:445-467.
8. Shijubo N, Itoh Y, Yamaguchi T, et al. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997, 10:1108-1114.
9. Rava M, Tares L, Lavi I, et al. Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population. J Allergy Clin Immunol 2013, 132:230-232.
10. Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008, 63:1058-1063.
11. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992, 5:1231-1238.
12. Pilette C, Godding V, Kiss R, et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:185-194.
13. Braido F, Riccio AM, Guerra L, et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage?. Respir Med 2007, 101:2119-2124.
14. Ye Q, Fujita M, Ouchi H, et al. Serum CC-10 in inflammatory lung diseases. Respiration 2004, 71:505-510.
15. Sin DD, Leung R, Gan WQ, Man SP Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007, 7:13.
16. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011, 365:1184-1192.
17. Park HY, Churg A, Wright JL, et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013, 188:1413-1419.
18. Lebowitz MD, Knudson RJ, Burrows B Tucson epidemiologic study of obstructive lung diseases. I: Methodology and prevalence of disease. Am J Epidemiol 1975, 102:137-152.
19. Eur Respir J 2002, 20:1071-1079. The European Community Respiratory Health Survey II.
20. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, et al. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants. Soz Praventivmed 2005, 50:245-263.
21. Taussig LM, Wright AL, Morgan WJ, Harrison HR, Ray CG The Tucson Children's Respiratory Study. I. Design and implementation of a prospective study of acute and chronic respiratory illness in children. Am J Epidemiol 1989, 129:1219-1231.
22. Custovic A, Simpson BM, Murray CS, Lowe L, Woodcock A The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy Immunol 2002, 13(suppl 15):32-37.
23. Ekstrom S, Magnusson J, Kull I, et al. Maternal BMI in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy 2015, 45:283-291.
24. Guerra S, Vasquez MM, Spangenberg A, Halonen M, Martinez FD Serum concentrations of club cell secretory protein (Clara) and cancer mortality in adults: a population-based, prospective cohort study. Lancet Respir Med 2013, 1:779-785.
25. Brown H, Prescott R Applied mixed models in medicine 2001, John Wiley & Sons, Chichester.
26. Kim DK, Cho MH, Hersh CP, et al. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186:1238-1247.
27. Bernard A, Nickmilder M, Dumont X Airway epithelium defects and risks of allergic diseases: multiple associations revealed by a biomarker study among adolescents. Am J Respir Crit Care Med 2015, 191:714-717.
28. Broeckaert F, Arsalane K, Hermans C, et al. Serum clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ Health Perspect 2000, 108:533-537.
29. Lagerkvist BJ, Bernard A, Blomberg A, et al. Pulmonary epithelial integrity in children: relationship to ambient ozone exposure and swimming pool attendance. Environ Health Perspect 2004, 112:1768-1771.
30. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011, 365:1567-1575.
31. Zhang Z, Kundu GC, Yuan CJ, et al. Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 1997, 276:1408-1412.
32. Stripp BR, Reynolds SD, Plopper CG, Boe IM, Lund J Pulmonary phenotype of CCSP/UG deficient mice: a consequence of CCSP deficiency or altered Clara cell function?. Ann N Y Acad Sci 2000, 923:202-209.
33. Snyder JC, Reynolds SD, Hollingsworth JW, Li Z, Kaminski N, Stripp BR Clara cells attenuate the inflammatory response through regulation of macrophage behavior. Am J Respir Cell Mol Biol 2010, 42:161-171.
34. Laucho-Contreras ME, Polverino F, Gupta K, et al. Protective role for club cell secretory protein-16 (CC16) in the development of chronic obstructive pulmonary disease. Eur Respir J 2015, published online Feb 9. 10.1183/09031936.0134214.
35. Zhu L, Di PY, Wu R, Pinkerton KE, Chen Y Repression of CC16 by cigarette smoke (CS) exposure. PLoS One 2015, 10:e0116159.
36. Lesur O, Bernard A, Arsalane K, et al. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995, 152:290-297.
37. Dierynck I, Bernard A, Roels H, De Ley M Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 1995, 12:205-210.
38. Levin SW, Butler JD, Schumacher UK, Wightman PD, Mukherjee AB Uteroglobin inhibits phospholipase A2 activity. Life Sci 1986, 38:1813-1819.
39. Mandal AK, Zhang Z, Ray R, et al. Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions. J Exp Med 2004, 199:1317-1330.
40. Vasanthakumar G, Manjunath R, Mukherjee AB, Warabi H, Schiffmann E Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochemical Pharmacol 1988, 37:389-394.
41. Gamez AS, Gras D, Petit A, et al. Supplementing defect in club cell secretory protein attenuates airway inflammation in COPD. Chest 2014, published online Dec 4. 10.1378/chest.14-1174.
42. Hermans C, Bernard A Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 1999, 159:646-678.
43. Helleday R, Segerstedt B, Forsberg B, et al. Exploring the time dependence of serum clara cell protein as a biomarker of pulmonary injury in humans. Chest 2006, 130:672-675.
44. Kenis G, Teunissen C, De Jongh R, Bosmans E, Steinbusch H, Maes M Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 2002, 19:228-235.